Treace Medical Concepts Inc
$ 1.94
3.74%
17 Apr - close price
- Market Cap 121,147,000 USD
- Current Price $ 1.94
- High / Low $ 1.98 / 1.86
- Stock P/E N/A
- Book Value 1.37
- EPS -0.93
- Next Earning Report 2026-05-14
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.17 %
- ROE -0.59 %
- 52 Week High 7.78
- 52 Week Low 1.17
About
Treace Medical Concepts, Inc., an orthopedic medical device company, is dedicated to the design, manufacture, and marketing of biological devices and / or solutions for foot and ankle surgeons in the United States. The company is headquartered in Ponte Vedra Beach, Florida.
Analyst Target Price
$4.25
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-26 | 2025-11-06 | 2025-08-07 | 2025-05-05 | 2025-02-25 | 2024-11-05 | 2024-08-06 | 2024-05-07 | 2024-02-27 | 2023-11-09 | 2023-08-08 | 2023-05-08 |
| Reported EPS | -0.0783 | -0.26 | -0.28 | -0.2468 | -0.0016 | -0.25 | -0.29 | -0.3 | -0.1 | -0.28 | -0.2 | -0.23 |
| Estimated EPS | -0.1521 | -0.28 | -0.29 | -0.3022 | -0.0427 | -0.27 | -0.29 | -0.3 | -0.09 | -0.26 | -0.24 | -0.23 |
| Surprise | 0.0738 | 0.02 | 0.01 | 0.0554 | 0.0411 | 0.02 | 0 | 0 | -0.01 | -0.02 | 0.04 | 0 |
| Surprise Percentage | 48.5207% | 7.1429% | 3.4483% | 18.3322% | 96.2529% | 7.4074% | 0% | 0% | -11.1111% | -7.6923% | 16.6667% | 0% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-14 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | -0.27 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: TMCI
2026-04-12 21:38:58
The article reports that the price target for Treace Medical Concepts (TMCI) has been increased by 12.28%, raising it to 4.08. No further details about the reasons for this change or the analyst responsible are provided in the snippet.
2026-04-11 21:09:38
This article reports that the price target for Treace Medical Concepts (TMCI) has been increased by 12.28%, reaching $4.08. This adjustment suggests a more optimistic outlook by analysts for the company's stock performance.
2026-04-11 19:39:41
The price target for Treace Medical Concepts (TMCI) has been increased by 12.28% to 4.08. This adjustment reflects an updated valuation for the company's stock.
2026-04-11 05:39:10
Wall Street Zen has upgraded Treace Medical Concepts (NASDAQ:TMCI) from a "strong sell" to a "sell" rating, despite the company's persistent fundamental weaknesses including negative EPS, net margin, and ROE. Overall analyst sentiment remains bearish, with a consensus "Reduce" rating and a target price of $4.77. The article highlights recent analyst downgrades, institutional trading activity, and the company's focus on its Lapiplasty 3D Bunion Correction System.
2026-04-10 22:09:12
Treace Medical Concepts announced a leadership transition, with Chief Commercial Officer Gaetano M. Guglielmino departing and his duties redistributed. The company also reported preliminary unaudited revenue for Q1 2026 between $47.0 million and $47.2 million, and updated its 2026 revenue outlook to $202 million to $212 million. Analysts currently rate TMCI as a Hold with a $1.00 price target, and TipRanks’ AI Analyst, Spark, rates it as Neutral due to persistent losses and a bearish technical trend.
2026-04-09 15:40:24
Stifel reiterated a Hold rating on Treace Medical Concepts Inc. (NASDAQ: TMCI) with an unchanged price target of $3.00, despite the stock being down 81% over the past year. The firm noted that first-quarter sales still represent a year-over-year decline but expressed encouragement that management is setting reasonable targets. Investors should consider that the company is quickly burning through cash, highlighting a key challenge in its turnaround process.
